Vodeći hrvatski proizvođač lijekova Pliva -- kojeg je nedavno otkupila američka firma Barr Pharmaceutical -- izvijestio je smanjenje sveukupnog prihoda od 12% za period januar-septembar.
Leading Croatian pharmaceutical producer Pliva -- which was recently acquired by US-based Barr Pharmaceutical -- reported a 12% decrease in its overall revenues from January-September.